{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:19:40Z","timestamp":1790785180528,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41386-018-0041-9","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T20:47:51Z","timestamp":1521060471000},"page":"1681-1690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies"],"prefix":"10.1038","volume":"43","author":[{"given":"Asli Ercan","family":"Dogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagri","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie-Anne","family":"Chouinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dost","family":"\u00d6ng\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"key":"41_CR1","unstructured":"WHO. WHO Media Centre, Fact Sheets, Mental Health. 2017. \n                    http:\/\/www.who.int\/mediacentre\/factsheets\/fs396\/en\/\n                    \n                   (accessed on 22 June 2017)"},{"key":"41_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1176\/ajp.2007.164.3.428","volume":"164","author":"MS Swartz","year":"2007","unstructured":"Swartz MS, Perkins DO, Stroup TS, Davis SM, Capuano G, Rosenheck RA, Investigators C. Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study. Am J Psychiatry. 2007;164:428\u201336. \n                    https:\/\/doi.org\/10.1176\/ajp.2007.164.3.428\n                    \n                  .","journal-title":"Am J Psychiatry"},{"key":"41_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1176\/appi.ajp.157.2.220","volume":"157","author":"M Tohen","year":"2000","unstructured":"Tohen M, Hennen J, Zarate CM Jr., Baldessarini RJ, Strakowski SM, Stoll AL, Cohen BM. Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry. 2000;157:220\u20138. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.157.2.220","journal-title":"Am J Psychiatry"},{"key":"41_CR4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijdevneu.2010.08.007","volume":"29","author":"HB Clay","year":"2011","unstructured":"Clay HB, Sillivan S, Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci. 2011;29:311\u201324. \n                    https:\/\/doi.org\/10.1016\/j.ijdevneu.2010.08.007","journal-title":"Int J Dev Neurosci"},{"key":"41_CR5","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/jcbfm.2011.175","volume":"32","author":"GA Dienel","year":"2012","unstructured":"Dienel GA. Brain lactate metabolism: the discoveries and the controversies. J Cereb Blood Flow Metab. 2012;32:1107\u201338. \n                    https:\/\/doi.org\/10.1038\/jcbfm.2011.175","journal-title":"J Cereb Blood Flow Metab"},{"key":"41_CR6","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1126\/science.3375817","volume":"240","author":"A Schurr","year":"1988","unstructured":"Schurr A, West CA, Rigor BM. Lactate-supported synaptic function in the rat hippocampal slice preparation. Science. 1988;240:1326\u20138.","journal-title":"Science"},{"key":"41_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11011-014-9595-3","volume":"30","author":"S Baltan","year":"2015","unstructured":"Baltan S. Can lactate serve as an energy substrate for axons in good times and in bad, in sickness and in health? Metab Brain Dis. 2015;30:25\u201330. \n                    https:\/\/doi.org\/10.1007\/s11011-014-9595-3","journal-title":"Metab Brain Dis"},{"key":"41_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fphys.2014.00043","volume":"5","author":"VA Ruffin","year":"2014","unstructured":"Ruffin VA, Salameh AI, Boron WF, Parker MD. Intracellular pH regulation by acid-base transporters in mammalian neurons. Front Physiol. 2014;5:43 \n                    https:\/\/doi.org\/10.3389\/fphys.2014.00043","journal-title":"Front Physiol"},{"key":"41_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/npp.2017.167","volume":"43","author":"H Hagihara","year":"2017","unstructured":"Hagihara H, Catts VS, Katayama Y, Shoji H, Takagi T, Huang FL, Miyakawa T. Decreased brain pH as a shared endophenotype of psychiatric disorders. Neuropsychopharmacology . 2017;43:459\u201368. \n                    https:\/\/doi.org\/10.1038\/npp.2017.167","journal-title":"Neuropsychopharmacology"},{"key":"41_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0074-7742(05)63002-4","volume":"63","author":"T Kato","year":"2005","unstructured":"Kato T. Mitochondrial dysfunction in bipolar disorder: from 31P-magnetic resonance spectroscopic findings to their molecular mechanisms. Int Rev Neurobiol. 2005;63:21\u201340. \n                    https:\/\/doi.org\/10.1016\/S0074-7742(05)63002-4","journal-title":"Int Rev Neurobiol"},{"key":"41_CR11","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/j.ejrad.2013.11.009","volume":"83","author":"J Novak","year":"2014","unstructured":"Novak J, Wilson M, Macpherson L, Arvanitis TN, Davies NP, Peet AC. Clinical protocols for (3)(1)P MRS of the brain and their use in evaluating optic pathway gliomas in children. Eur J Radiol. 2014;83:e106\u201312. \n                    https:\/\/doi.org\/10.1016\/j.ejrad.2013.11.009","journal-title":"Eur J Radiol"},{"key":"41_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0925-4927(01)00082-8","volume":"106","author":"A Yildiz","year":"2001","unstructured":"Yildiz A, Sachs GS, Dorer DJ, Renshaw PF. 31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: a meta-analysis. Psychiatry Res. 2001;106:181\u201391.","journal-title":"Psychiatry Res"},{"key":"41_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.239","volume":"6","author":"LM Rowland","year":"2016","unstructured":"Rowland LM, Pradhan S, Korenic S, Wijtenburg SA, Hong LE, Edden RA, Barker PB. Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study. Transl Psychiatry. 2016;6:e967 \n                    https:\/\/doi.org\/10.1038\/tp.2016.239","journal-title":"Transl Psychiatry"},{"key":"41_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.biopsych.2004.06.012","volume":"56","author":"SD Friedman","year":"2004","unstructured":"Friedman SD, Dager SR, Parow A, Hirashima F, Demopulos C, Stoll AL, Renshaw PF. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry. 2004;56:340\u20138. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2004.06.012","journal-title":"Biol Psychiatry"},{"key":"41_CR15","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/archpsyc.61.5.450","volume":"61","author":"SR Dager","year":"2004","unstructured":"Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, Renshaw PF. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry. 2004;61:450\u20138. \n                    https:\/\/doi.org\/10.1001\/archpsyc.61.5.450","journal-title":"Arch Gen Psychiatry"},{"key":"41_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.84","volume":"2","author":"RO Brady Jr.","year":"2012","unstructured":"Brady RO Jr., Cooper A, Jensen JE, Tandon N, Cohen B, Renshaw P, Ongur D. A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder. Transl Psychiatry. 2012;2:e160. \n                    https:\/\/doi.org\/10.1038\/tp.2012.84","journal-title":"Transl Psychiatry"},{"key":"41_CR17","doi-asserted-by":"publisher","unstructured":"Soeiro-de-Souza MG, Pastorello BF, Leite Cda C, Henning A, Moreno, RA, Garcia Otaduy MC. Dorsal Anterior Cingulate Lactate and Glutathione Levels in Euthymic Bipolar I Disorder: 1H-MRS study. Int J Neuropsychopharmacol. 2016;19. \n                    https:\/\/doi.org\/10.1093\/ijnp\/pyw032","DOI":"10.1093\/ijnp\/pyw032"},{"key":"41_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/JCP.0000000000000616","volume":"37","author":"R Machado-Vieira","year":"2017","unstructured":"Machado-Vieira R, Zanetti MV, Otaduy MC, De Sousa RT, Soeiro-de-Souza MG, Costa AC, Gattaz WF. Increased brain lactate during depressive episodes and reversal effects by lithium monotherapy in drug-naive bipolar disorder: a 3-T 1H-MRS study. J Clin Psychopharmacol. 2017;37:40\u20135. \n                    https:\/\/doi.org\/10.1097\/JCP.0000000000000616","journal-title":"J Clin Psychopharmacol"},{"key":"41_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pscychresns.2013.02.008","volume":"213","author":"J Xu","year":"2013","unstructured":"Xu J, Dydak U, Harezlak J, Nixon J, Dzemidzic M, Gunn AD, Anand A. Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation. Psychiatry Res. 2013;213:235\u201341. \n                    https:\/\/doi.org\/10.1016\/j.pscychresns.2013.02.008","journal-title":"Psychiatry Res"},{"key":"41_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pscychresns.2013.03.004","volume":"213","author":"WJ Chu","year":"2013","unstructured":"Chu WJ, Delbello MP, Jarvis KB, Norris MM, Kim MJ, Weber W, Adler CM. Magnetic resonance spectroscopy imaging of lactate in patients with bipolar disorder. Psychiatry Res. 2013;213:230\u20134. \n                    https:\/\/doi.org\/10.1016\/j.pscychresns.2013.03.004","journal-title":"Psychiatry Res"},{"key":"41_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0925-4927(94)90016-7","volume":"55","author":"T Shioiri","year":"1994","unstructured":"Shioiri T, Kato T, Inubushi T, Murashita J, Takahashi S. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Psychiatry Res. 1994;55:223\u201335. \n                    https:\/\/doi.org\/10.1016\/0165-1781(95)91247-B","journal-title":"Psychiatry Res"},{"key":"41_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0925-4927(95)02752-J","volume":"61","author":"T Kato","year":"1995","unstructured":"Kato T, Shioiri T, Murashita J, Hamakawa H, Inubushi T, Takahashi S. Lateralized abnormality of high-energy phosphate and bilateral reduction of phosphomonoester measured by phosphorus-31 magnetic resonance spectroscopy of the frontal lobes in schizophrenia. Psychiatry Res. 1995;61:151\u201360.","journal-title":"Psychiatry Res"},{"key":"41_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamapsychiatry.2013.2287","volume":"71","author":"F Du","year":"2014","unstructured":"Du F, Cooper AJ, Thida T, Sehovic S, Lukas SE, Cohen BM, Ongur D. In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy. JAMA Psychiatry. 2014;71:19\u201327. \n                    https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.2287","journal-title":"JAMA Psychiatry"},{"key":"41_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0925-4927(02)00007-0","volume":"114","author":"S Riehemann","year":"2002","unstructured":"Riehemann S, Hubner G, Smesny S, Volz HP, Sauer H. Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?-a (31)P-MRS study on three different patient groups. Psychiatry Res. 2002;114:113\u20137.","journal-title":"Psychiatry Res"},{"key":"41_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0165-0327(92)90099-R","volume":"26","author":"T Kato","year":"1992","unstructured":"Kato T, Takahashi S, Shioiri T, Inubushi T. Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord. 1992;26:223\u201330.","journal-title":"J Affect Disord"},{"key":"41_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0165-0327(93)90097-4","volume":"27","author":"T Kato","year":"1993","unstructured":"Kato T, Takahashi S, Shioiri T, Inubushi T. Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J Affect Disord. 1993;27:53\u20139.","journal-title":"J Affect Disord"},{"key":"41_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0925-4927(94)90010-8","volume":"55","author":"T Kato","year":"1994","unstructured":"Kato T, Shioiri T, Murashita J, Hamakawa H, Inubushi T, Takahashi S. Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder. Psychiatry Res. 1994;55:41\u201350.","journal-title":"Psychiatry Res"},{"key":"41_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1440-1819.2004.01197.x","volume":"58","author":"H Hamakawa","year":"2004","unstructured":"Hamakawa H, Murashita J, Yamada N, Inubushi T, Kato N, Kato T. Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder. Psychiatry Clin Neurosci. 2004;58:82\u20138.","journal-title":"Psychiatry Clin Neurosci"},{"key":"41_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s004060050054","volume":"248","author":"T Kato","year":"1998","unstructured":"Kato T, Murashita J, Kamiya A, Shioiri T, Kato N, Inubushi T. Decreased brain intracellular pH measured by 31P-MRS in bipolar disorder: a confirmation in drug-free patients and correlation with white matter hyperintensity. Eur Arch Psychiatry Clin Neurosci. 1998;248:301\u20136.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"41_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0165-0327(94)90116-3","volume":"31","author":"T Kato","year":"1994","unstructured":"Kato T, Takahashi S, Shioiri T, Murashita J, Hamakawa H, Inubushi T. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord. 1994;31:125\u201333.","journal-title":"J Affect Disord"},{"key":"41_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1017\/S0033291799001439","volume":"30","author":"J Murashita","year":"2000","unstructured":"Murashita J, Kato T, Shioiri T, Inubushi T, Kato N. Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopy. Psychol Med. 2000;30:107\u201315.","journal-title":"Psychol Med"},{"key":"41_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1176\/ajp.152.6.915","volume":"152","author":"RF Deicken","year":"1995","unstructured":"Deicken RF, Fein G, Weiner MW. Abnormal frontal lobe phosphorous metabolism in bipolar disorder. Am J Psychiatry. 1995;152:915\u20138. \n                    https:\/\/doi.org\/10.1176\/ajp.152.6.915","journal-title":"Am J Psychiatry"},{"key":"41_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-0327(94)00089-R","volume":"33","author":"RF Deicken","year":"1995","unstructured":"Deicken RF, Weiner MW, Fein G. Decreased temporal lobe phosphomonoesters in bipolar disorder. J Affect Disord. 1995;33:195\u20139.","journal-title":"J Affect Disord"},{"key":"41_CR34","doi-asserted-by":"publisher","unstructured":"Du F, Yuksel C, Chouinard VA, Huynh P, Ryan K, Cohen BM, Ongur D. Abnormalities in high-energy phosphate metabolism in first-episode bipolar disorder measured using 31P-magnetic resonance spectroscopy. Biol Psychiatry. 2017. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2017.03.025","DOI":"10.1016\/j.biopsych.2017.03.025"},{"key":"41_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1037\/1064-1297.16.3.199","volume":"16","author":"JE Jensen","year":"2008","unstructured":"Jensen JE, Daniels M, Haws C, Bolo NR, Lyoo IK, Yoon SJ, Renshaw PF. Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients. Exp Clin Psychopharmacol. 2008;16:199\u2013206. \n                    https:\/\/doi.org\/10.1037\/1064-1297.16.3.199","journal-title":"Exp Clin Psychopharmacol"},{"key":"41_CR36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/bdi.12339","volume":"17","author":"XF Shi","year":"2015","unstructured":"Shi XF, Carlson PJ, Sung YH, Fiedler KK, Forrest LN, Hellem TL, Kondo DG. Decreased brain PME\/PDE ratio in bipolar disorder: a preliminary (31) P magnetic resonance spectroscopy study. Bipolar Disord. 2015;17:743\u201352. \n                    https:\/\/doi.org\/10.1111\/bdi.12339","journal-title":"Bipolar Disord"},{"key":"41_CR37","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.pnpbp.2007.04.009","volume":"31","author":"DJ Kim","year":"2007","unstructured":"Kim DJ, Lyoo IK, Yoon SJ, Choi T, Lee B, Kim JE, Renshaw PF. Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:1182\u20138. \n                    https:\/\/doi.org\/10.1016\/j.pnpbp.2007.04.009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"41_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/da.1076","volume":"14","author":"ME Layton","year":"2001","unstructured":"Layton ME, Friedman SD, Dager SR. Brain metabolic changes during lactate-induced panic: effects of gabapentin treatment. Depress Anxiety. 2001;14:251\u20134.","journal-title":"Depress Anxiety"},{"key":"41_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0925-4927(97)00066-8","volume":"76","author":"SR Dager","year":"1997","unstructured":"Dager SR, Richards T, Strauss W, Artru A. Single-voxel 1H-MRS investigation of brain metabolic changes during lactate-induced panic. Psychiatry Res. 1997;76:89\u201399.","journal-title":"Psychiatry Res"},{"key":"41_CR40","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1176\/ajp.152.5.666","volume":"152","author":"SR Dager","year":"1995","unstructured":"Dager SR, Strauss WL, Marro KI, Richards TL, Metzger GD, Artru AA. Proton magnetic resonance spectroscopy investigation of hyperventilation in subjects with panic disorder and comparison subjects. Am J Psychiatry. 1995;152:666\u201372. \n                    https:\/\/doi.org\/10.1176\/ajp.152.5.666","journal-title":"Am J Psychiatry"},{"key":"41_CR41","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.biopsych.2012.12.015","volume":"73","author":"RJ Maddock","year":"2013","unstructured":"Maddock RJ, Buonocore MH, Miller AR, Yoon JH, Soosman SK, Unruh AM. Abnormal activity-dependent brain lactate and glutamate+glutamine responses in panic disorder. Biol Psychiatry. 2013;73:1111\u20139. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2012.12.015","journal-title":"Biol Psychiatry"},{"key":"41_CR42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","volume":"160","author":"MC Ryan","year":"2003","unstructured":"Ryan MC, Collins P, Thakore JH. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry. 2003;160:284\u20139. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.160.2.284","journal-title":"Am J Psychiatry"},{"key":"41_CR43","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1176\/appi.ajp.2007.07020233","volume":"164","author":"G Venkatasubramanian","year":"2007","unstructured":"Venkatasubramanian G, Chittiprol S, Neelakantachar N, Naveen MN, Thirthall J, Gangadhar BN, Shetty KT. Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia. Am J Psychiatry. 2007;164:1557\u201360. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.2007.07020233","journal-title":"Am J Psychiatry"},{"key":"41_CR44","doi-asserted-by":"publisher","first-page":"997","DOI":"10.4088\/JCP.08m04508","volume":"70","author":"SK Verma","year":"2009","unstructured":"Verma SK, Subramaniam M, Liew A, Poon LY. Metabolic risk factors in drug-naive patients with first-episode psychosis. J Clin Psychiatry. 2009;70:997\u20131000. \n                    https:\/\/doi.org\/10.4088\/JCP.08m04508","journal-title":"J Clin Psychiatry"},{"key":"41_CR45","doi-asserted-by":"publisher","first-page":"8270","DOI":"10.1073\/pnas.1205902109","volume":"109","author":"VA Magnotta","year":"2012","unstructured":"Magnotta VA, Heo HY, Dlouhy BJ, Dahdaleh NS, Follmer RL, Thedens DR, Wemmie JA. Detecting activity-evoked pH changes in human brain. Proc Natl Acad Sci USA. 2012;109:8270\u20133. \n                    https:\/\/doi.org\/10.1073\/pnas.1205902109","journal-title":"Proc Natl Acad Sci USA"},{"key":"41_CR46","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1460-9568.2004.03524.x","volume":"20","author":"Y Shirayama","year":"2004","unstructured":"Shirayama Y, Yano T, Takahashi K, Takahashi S, Ogino T. In vivo31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest. European journal of neuroscience. 2004;20:749\u2013756.","journal-title":"European journal of neuroscience"},{"key":"41_CR47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0006-3223(98)00061-4","volume":"44","author":"HP Volz","year":"1998","unstructured":"Volz HP, Rzanny R, R\u00f6ssger G, H\u00fcbner G, Kreitschmann-Andermahr I, Kaiser WA, Sauer H. 31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics\u2014a study including 50 patients and 36 controls. Biological Psychiatry. 1998;44:399\u2013404.","journal-title":"Biological Psychiatry"},{"key":"41_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0925-4927(97)00047-4","volume":"76","author":"HP Volz","year":"1997","unstructured":"Volz HP, Rzanny R, R\u00f6\u03b2ger G, H\u00fcbner G, Kreitschmann-Andermahr I, Kaiser WA, Sauer H. Decreased energy demanding processes in the frontal lobes of schizophrenics due to neuroleptics? A 31P-magneto-resonance spectroscopic study. Psychiatry Research: Neuroimaging. 1997a;76:123\u2013129.","journal-title":"Psychiatry Research: Neuroimaging"},{"key":"41_CR49","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0006-3223(96)00062-5","volume":"41","author":"HP Volz","year":"1997","unstructured":"Volz HP, Rzanny R, May S, Hegewald H, Preui\u03b2ler B, Hajek M, Kaiser WA, Sauer H. 31P magnetic resonance spectroscopy in the dorsolateral prefrontal cortex of schizophrenics with a volume selective technique\u2014preliminary findings. Biological psychiatry. 1997b;41:644\u2013648.","journal-title":"Biological psychiatry"},{"key":"41_CR50","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/0006-3223(94)90613-0","volume":"36","author":"RF Deicken","year":"1994","unstructured":"Deicken RF, Calabrese G, Merrin EL, Meyerhoff DJ, Dillon WP, Weiner MW, Fein G. 31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia. Biological psychiatry. 1994;36:503\u2013510.","journal-title":"Biological psychiatry"},{"key":"41_CR51","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0006-3223(92)90139-Q","volume":"32","author":"G Calabrese","year":"1992","unstructured":"Calabrese G, Deicken RF, Fein G, Merrin EL, Schoenfeld F, Wiener MW. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biological Psychiatry. 1992;32:26\u201332.","journal-title":"Biological Psychiatry"},{"key":"41_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1600-0447.1992.tb03297.x","volume":"86","author":"T Fujimoto","year":"1992","unstructured":"Fujimoto T, Nakano T, Takano T, Hokazono Y, Asakura T, Tsuji T. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging. Acta Psychiatrica Scandinavica. 1992;86:455\u2013462.","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"41_CR53","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/0006-3223(91)90256-L","volume":"29","author":"E O'Callaghan","year":"1991","unstructured":"O'Callaghan E, Redmond O, Ennis R, Stack J, Kinsella A, Ennis JT, Waddington JL. Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy. Biological psychiatry. 1991;29:1149\u20131152.","journal-title":"Biological psychiatry"},{"key":"41_CR54","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1001\/archpsyc.1991.01810300075011","volume":"48","author":"JW Pettegrew","year":"1991","unstructured":"Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, Allen M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in firstepisode, drug-naive schizophrenics: A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Archives of general psychiatry. 1991;48:563\u2013568.","journal-title":"Archives of general psychiatry"},{"key":"41_CR55","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1001\/archpsyc.1991.01810300090013","volume":"48","author":"P Williamson","year":"1991","unstructured":"Williamson P, Drost D, Stanley J, Carr T, Morrison S, Merskey H. Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls. Archives of general psychiatry. 1991;48:578\u2013578.","journal-title":"Archives of general psychiatry"},{"key":"41_CR56","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.schres.2017.02.024","volume":"187","author":"VA Chouinard","year":"2017","unstructured":"Chouinard VA, Kim SY, Valeri L, Yuksel C, Ryan KP, Chouinard G, Cohen Bruce M, Du F, \u00d6ng\u00fcr D. Brain bioenergetics and redox state measured by 31P magnetic resonance spectroscopy in unaffected siblings of patients with psychotic disorders. Schizophrenia research. 2017;187:11\u201316.","journal-title":"Schizophrenia research"},{"key":"41_CR57","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/mp.2015.13","volume":"20","author":"C Yuksel","year":"2015","unstructured":"Yuksel C, Du F, Ravichandran C, Goldbach JR, Thida T, Lin P, Dora B, Gelda J, O'Connor L, Sehovic S, Gruber S. Abnormal high-energy phosphate molecule metabolism during regional brain activation in patients with bipolar disorder. Molecular psychiatry. 2015;20:1079.","journal-title":"Molecular psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0041-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0041-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-018-0041-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:33Z","timestamp":1684616553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-018-0041-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1038\/s41386-018-0041-9","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"assertion":[{"value":"25 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D\u00d6 served on a Scientific Advisory Board for Neurocrine Inc. in 2017. The reamining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}